109 0 Kommentare Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024.

Für Sie zusammengefasst

Spexis AG granted extension for 2023 report until May 31, 2024.
Delay due to discussions with legal counsel and creditor.
Expects to publish unaudited financial statements by end of May 2024.

Spexis AG / Key word(s): Miscellaneous
Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024.

30-Apr-2024 / 20:30 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.

Ad hoc announcement pursuant to Art. 53 LR

Allschwil, Switzerland, April 30, 2024

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024.

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that the company has been granted an extension to publish its 2023 annual report from SIX Exchange Regulation AG (“SIX”), with said publication to occur no later than 31 May 2024.

Paragraph I of the SIX decision dated April 29, 2024 reads as follows:

I. The exemption request of Spexis (Issuer) dated 29 April 2024 regarding an extension of the deadline to publish its 2023 annual report and to file such report with SIX Exchange Regulation AG until 31 May 2024 at the latest is granted with the following reservation (lit.a) and under the following conditions (lit. b):

a. SIX Exchange Regulation AG reserves the right to suspend trading of the registered shares of the Issuer in case its 2023 annual report is not published in accordance with the provisions on ad hoc publicity (Art. 53 of the Listing Rules [LR] in connection with the Directive on Ad hoc Publicity [DAH]) and not filed with SIX Exchange Regulation AG until Friday, 31 May 2024, 11.59 pm CET, at the latest.

b. Spexis is required to publish a notice in accordance with the provisions on ad hoc publicity (Art. 53 LR in connection with the DAH) concerning this decision until Tuesday, 30 April 2024, 11.59 pm CET, at the latest. The notice must contain:

the unaltered reproduction of the wording of para. I. of this decision, placed in a prominent position;
the reasons for the application of the Issuer requesting an extension of the deadline to publish its 2023 annual report and to file such report with SIX Exchange Regulation AG.

Seite 1 von 3
Seite 2 ►